English

This information card lists possible adverse reactions and/or side effects patients may have to TB medication.

This information card provides information on the multiple significant drug interactions between TB medications; specifically, INH, rifampin, and other medications and the effect of the interaction. It also provides information on food interactions with TB drugs.

This poster serves as a quick reference to the Revised Treatment of Tuberculosis Guidelines published in February 2003 by the American Thoracic Society, CDC, and the Infectious Disease Society of America. It contains information on treatment during the initial and continuation dosing phases, the range of total doses and the rating, information on PZA and ethambutol dosing, dosing recommendations for adult patients with reduced renal function as well as for those receiving hemodialysis, and information on how to monitor those patients.

This pamphlet explains TB transmission, the difference between latent TB infection (LTBI) and TB disease, and the treatment for LTBI.

This fact sheet discusses TB transmission, infection, disease, diagnosis through a skin test, and treatment.

This report presents a tools package for public-private mix initiatives for DOTS implementation (PPM-DOTS) as a means of TB control. The purpose is to help national TB program (NTP) managers begin involving private providers (PPs) in DOTS implementation and to sustain collaboration.

This report discusses the economic, psychological, and social impacts of TB and the strategies that households use to cope with them.

This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.

This report describes World TB Day events and activities that took place on March 24, 2000 to raise public awareness about the extent of the TB epidemic in various countries and territories around the world.

This manual presents guidelines for employers to implement TB control activities in the workplace.